Kidney care advocates praise new appointees; advocacy group notes the task force creates financial effects on patients.
News|Videos|March 12, 2025
What tariffs mean for the medical device industry - and who will pay for them?
Author(s)Todd Shryock
Tariffs could play a big role in what you pay for medical devices, and they may disrupt the entire industry
Advertisement
The Trump administration is applying
Medical Economics spoke with
Advertisement
Related to this article
A primary-care voucher model would pay practices upfront for predictable care and leave insurance to cover catastrophic risk, cutting administrative burden and giving physicians time back with patients.
CMS chief says outcomes-based pay can help patients while finally ending physicians' box-checking frustration.
The 3-part federal plan targets costs, red tape and corporate consolidation across commercial health insurance.
RFK Jr. appoints members to fill a panel that has not met in more than a year, but is influential on primary care.
Ballard Spahr says the Hikma v. Amarin decision makes it harder for brand-name drugmakers to sue over "skinny label" generics — a shift likely to speed generic competition and lower costs for patients
Reactions from five leading organizations were among thousands of public comments on the draft document.
Physician groups back ACCESS Model but warn CMS against care fragmentation
Advertisement
Advertisement
Trending on Medical Economics
1
10 MGMA 2026 sessions physicians can’t afford to miss
2
Medicare's plan to pay half for same-day care, with Anders Gilberg of MGMA
3
Why primary care may need less insurance, not more
4
Rapid UTI test that returns antibiotic susceptibility in hours gets FDA breakthrough designation
5